AlaviALeonardJC: Correlative studies of the brain with positron emission tomography, nuclear magnetic resonance and x-ray computed tomography. In: Cerebral Blood Flow and Metabolism Measurement. Hartmann/Hoyer Eds. Springler-VerlagBerlin Heidelberg1985: 525–539.
2.
BaronJCBousserMG: Reversal of focal «misery-perfusion syndrome» by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. Stroke12: 454–459, 1981.
3.
BaronJCD'AntonaR: Effects of thalamic stroke on energy metabolism of the cerebral cortex. A positron tomography study in man. Brain109: 1243–1259, 1986.
4.
BensonDFKuhlDE: The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol40: 711–714, 1983.
5.
ChawlukJBAlaviA: Positron emission tomography in aging and dementia: Effect of cerebral atrophyJ Nucl Med28: 431–437, 1987.
6.
CutlerNRHaxbyJV: Clinical history, brain metabolism and neuropsychological function in Alzheimer's disease. Ann Neurol18: 298–309, 1985.
7.
de LeonMJGeorgeAX: Positron emission tomography and computed tomography assessment of the aging human brain. J Comput Assist Tomogr8: 88–94, 1984.
8.
D'AntonaRBaronJC: Subcortical dementia. Frontal cortex hypometabolism detected by positron emission tomography in patients with progressive supranuclear palsy. Brain108: 785–799, 1985.
9.
Di ChiroGDeLaPazRL: Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology32: 1323–1329, 1982.
10.
DuaraRMargolinRA: Cerebral glucose utilization as measured with positron emission tomography in 21 resting healthy men between the age of 21 to 83 years. Brain106: 761–775, 1983.
11.
EngelJKuhlDE: Comparative localizationof epileptic foci in partial epilepsy by PET and EEG. Ann Neurol12: 529–537, 1982.
12.
FazekasFAlaviA: Comparison of CT, MR and PET in Alzheimer's dementia and normal aging. J Nucl Med30: 1607–1615, 1989.
FrackowiakRSJLenziGL: Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 150 and positron emission tomography: Theory, procedure and normal values. J Comput Assist Tomogr4: 727–736, 1980.
15.
GibbsJMWiseRJ: Cerebral hemodynamics in occlusive carotid-artery disease. Lancet1: 933–934, 1985.
16.
HaxbyJVDuaraR: Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J Cereb Blood Flow Metab5: 193–200, 1985.
17.
HeissWDHerholzK: PET, CT and MR imaging in cerebrovascular disease. J Comput Assist Tomogr10: 903–911, 1986.
18.
KuhlDEEngelJ: Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13Nh3. Ann Neurol8: 348–360, 1980.
19.
KuhlDEMetterEJ: Effects of human aging on patterns of local cerebral glucose utilization determined by the (18F) fluorodeoxyglucose method. J Cereb Blood Flow Metab2: 163–171, 1982.
20.
LiljaALundqvistH: Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions. Acta Radiologica30: 121–128, 1989.
21.
LeendersKLPeraniD: The effect of age on cerebral blood flow, blood volume and oxygen utilization. Brain113: 27–47, 1990.
22.
LenziGLFrackowiakRSJJonesT: Cerebral oxygen metabolism and blood flow in human cerebral infarction. J Cereb Blood Flow Metab2: 321–335, 1982.
23.
MetterEJWasterlainCG: 18FDG positron emission computed tomography: A study of aphasia. Ann Neurol10: 173–183, 1981.
24.
PantanoPBaronJC: Regional cerebral blood flow and oxygen consumption in human aging. Strokel5: 635–641, 1984.
25.
PerlmutterJSPowersWJ: Regional asymmetries of cerebral blood flow, blood volume and oxygen utilization and extraction in normal subjects. J Cereb Blood Flow Metab7: 64–67, 1987.
26.
PowersWJRaichleME: Positron emission tomography and its application to the study of cerebrovascular disease in man. Stroke16: 361–376, 1985.
27.
TheodoreWHDorwartR: Neuroimaging in refractory partial seizures: Comparison of PET, CT and MRI. Neurology36: 750–759, 1986.
